1. Home
  2. BCML vs CUVL Comparison

BCML vs CUVL Comparison

Compare BCML & CUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayCom Corp

BCML

BayCom Corp

HOLD

Current Price

$30.87

Market Cap

364.8M

Sector

Finance

ML Signal

HOLD

Logo Clinuvel Pharmaceuticals Limited American Depositary Shares

CUVL

Clinuvel Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$4.94

Market Cap

374.2M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCML
CUVL
Founded
2004
1999
Country
United States
Australia
Employees
N/A
16
Industry
Major Banks
Miscellaneous
Sector
Finance
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
364.8M
374.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
BCML
CUVL
Price
$30.87
$4.94
Analyst Decision
Hold
Analyst Count
4
0
Target Price
★ $33.00
N/A
AVG Volume (30 Days)
★ 55.5K
5.3K
Earning Date
10-22-2026
08-27-2026
Dividend Yield
★ 3.93%
0.56%
EPS Growth
★ 3.81
N/A
EPS
★ 0.11
N/A
Revenue
N/A
N/A
Revenue This Year
$8.66
$0.47
Revenue Next Year
$5.59
$6.25
P/E Ratio
$277.23
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.78
$4.88
52 Week High
$34.98
$8.20

Technical Indicators

Market Signals
Indicator
BCML
CUVL
Relative Strength Index (RSI) 52.19 42.09
Support Level $29.69 $4.91
Resistance Level $31.13 $5.40
Average True Range (ATR) 0.71 0.19
MACD -0.04 0.02
Stochastic Oscillator 62.60 36.88

Price Performance

Historical Comparison
BCML
CUVL

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.

About CUVL Clinuvel Pharmaceuticals Limited American Depositary Shares

Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.

Share on Social Networks: